Induction of Cytokine Expression in Leukocytes in Acute Myocardial Infarction  by Marx, Nikolaus et al.
Induction of Cytokine Expression in Leukocytes in Acute
Myocardial Infarction
NIKOLAUS MARX, MD, FRANZ-JOSEF NEUMANN, MD, ILKA OTT, MD,
MEINRAD GAWAZ, MD, WERNER KOCH, PHD, TOBIAS PINKAU, BSC, ALBERT SCHO¨MIG, MD
Munich, Germany
Objectives. This study sought to investigate whether cytokine
expression in leukocytes may be induced by plasma from the
reperfused heart of patients with an acute myocardial infarction
(MI).
Background. Reperfusion in acute MI is associated with dele-
terious local and systemic inflammatory responses that are regu-
lated by cytokines. Induction of cytokine expression in resident
leukocytes could contribute to inflammatory responses of the
ischemic and reperfused heart.
Methods. Blood samples of 10 patients with an acute MI were
obtained simultaneously from the coronary sinus and the aorta
before and 5 min after recanalization of the coronary occlusion.
Ten patients with elective percutaneous transluminal coronary
angioplasty served as a control group. We incubated leukocytes
from healthy donors with plasma samples and analyzed mRNA
expression of interleukin (IL)-1beta, IL-6, IL-8 and tumor necrosis
factor-alpha (TNF-alpha) by Northern blot analysis.
Results. In patients with an acute MI, plasma obtained from
the coronary sinus after recanalization increased the mRNA
expression of IL-1beta and IL-8 compared with that of plasma
before recanalization (median [quartiles] difference before vs.
after recanalization: 34.5 [4, 137], p 5 0.017, for IL-1beta; 18.5 [4,
35], p 5 0.032, for IL-8) and simultaneously obtained aortic
plasma (median [quartiles] coronary sinus–aortic differences
after recanalization: 45.5 [23, 115], p 5 0.021, for IL-1beta; 16 [4,
52], p 5 0.005, for IL-8). No induction of IL-6 and TNF-alpha
expression could be observed. No changes found in the study
patients were detectable in the control group.
Conclusions. Plasma from the ischemic and reperfused heart
stimulates the expression of IL-1beta and IL-8 in leukocytes.
Therefore, leukocyte-derived cytokines may contribute to the regula-
tion of cardiac inflammatory responses in patients with an acute MI.
(J Am Coll Cardiol 1997;30:165–70)
©1997 by the American College of Cardiology
In acute myocardial infarction (MI), early recanalization of the
occluded artery can salvage myocardium and improve clinical
outcome (1–5). Despite these beneficial effects of timely
restoration of coronary blood flow, local inflammatory re-
sponses of the ischemic and reperfused heart exert deleterious
effects on the myocardium (6–11). Besides these local reac-
tions, a systemic inflammatory response syndrome develops in
patients with acute MI, and a number of clinical studies
(12–14) have demonstrated an adverse impact of systemic
inflammatory response syndromes on clinical outcome.
Several experimental studies (15–17) have shown that cyto-
kines are important regulators of inflammatory reactions dur-
ing reperfusion. Among those, the predominantly leukocyte-
derived cytokines tumor necrosis factor-alpha (TNF-alpha)
and interleukin (IL)-1beta appear to play a key role due to their
ability to induce secondary cytokines, such as IL-6 and IL-8
(18–20). IL-8 has potent actions in the recruitment and local
activation of neutrophils (21,22), whereas IL-6, in concert with
IL-1beta and TNF-alpha, induces predominantly systemic in-
flammatory responses (23). In patients with acute MI, we
recently found a cardiac release of IL-6 and IL-8 during
reperfusion after direct percutaneous transluminal coronary
angioplasty (PTCA) of the infarct-related coronary artery, but
there was no concomitant release of IL-1beta or TNF-alpha (6).
However, the lack of detectable transcardiac gradients in
TNF-alpha and IL-1beta did not exclude a paracrine release by
resident leukocytes and macrophages that may stimulate the
endothelial production of IL-6 and IL-8 (19,20).
The present study sought to test the hypothesis that the
ischemic and reperfused coronary circulation in acute MI
represents a proinflammatory environment, capable of induc-
ing cytokine expression in resident leukocytes. We therefore
obtained coronary venous and aortic plasma before and after
recanalization of the occluded artery in acute MI and exam-
ined its effect on the expression of IL-1beta, IL-6, IL-8 and
TNF-alpha in leukocytes.
Methods
Patients. The study group included 10 patients with an
acute anterior MI who were admitted to the hospital within 3
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to 9 h of the onset of pain (median time delay 7 h). The
diagnosis of acute MI was based on a history of prolonged
ischemic chest pain and characteristic electrocardiographic
changes. All patients underwent immediate coronary angiog-
raphy, which revealed an occluded left anterior descending
coronary artery (LAD) that was recanalized successfully by
primary PTCA.
The control group included 10 patients with elective PTCA
for a LAD stenosis within 19 to 44 days of successful throm-
bolysis for acute anterior MI. Indication for PTCA was based
on a history of stable angina or exercise stress test, or both, in
the presence of a significant (.70%) LAD stenosis.
Patients with concomitant noncardiac diseases, such as
inflammatory disorders, malignancy or infection, were omitted
from the study. The usual medication of the patients was not
changed, and no patient was taking antiinflammatory agents,
except for aspirin (100 mg twice daily). Table 1 shows the
baseline characteristics of the study and control groups.
The study was approved by the institutional ethics commit-
tee, and informed written consent was obtained from all
patients.
Study protocol. Before the study, all patients with an acute
MI were given 5,000 IU of unfractionated heparin intrave-
nously, 500 mg of aspirin, one to three injections of 5 mg of
metoprolol and one to two injections of 5 mg of morphine,
depending on individual response. To obtain a systolic blood
pressure between 100 and 120 mm Hg, patients were main-
tained on intravenous infusions of nitroglycerin (0.24 to
2.4 mg/h). Before coronary angiography, an additional dose of
10,000 IU of heparin was given intraarterially. Coronary
angiography was performed by the transfemoral approach.
While one operator placed the guiding catheter, a second
operator cannulated the coronary sinus with a 7F multipurpose
catheter using the brachial approach. If the coronary anatomy
was judged suitable for mechanical recanalization, the opera-
tors immediately proceeded to PTCA using fixed-wire balloon
catheters (ACE, Scimed Life Systems).
Two sets of blood samples were obtained simultaneously
from the coronary sinus and the guiding catheter. The first set
was taken after the guide wire of the balloon was placed at the
proximal end of the occlusion; the second was taken 5 min
after the restoration of blood flow in the occluded coronary
artery.
In the control patients, PTCA was also performed with the
femoral approach, and the coronary sinus was cannulated
through an antecubital vein. Identical to the study patients,
control patients received an intravenous dose of 500 mg of
aspirin and 15,000 IU of heparin intraarterially immediately
after femoral arterial access was obtained. Two sets of blood
samples were again obtained simultaneously from the guiding
catheter and the coronary sinus: the first after the guide wire
for the balloon catheter was positioned; the second 5 min after
the first balloon inflation.
In both the control and study groups, all blood samples
were obtained over a defined period of 1 min and anticoagu-
lated with 1:10 (vol/vol) citrate, phosphate buffer, dextrose and
adenine (CPDA) (Greiner, Nu¨rtingen, Germany). The blood
samples were put on ice and processed immediately, as indi-
cated below. For immunoassay and incubation, plasma samples
were stored at 2120°C until final processing.
Cytokine enzyme-linked immunosorbent assay. Concen-
trations of IL-1beta, IL-6, IL-8 and TNF-alpha were deter-
mined by sandwich-type immunoassay (IL-6 and TNF-alpha:
IEMA, Immunotech; IL-1beta, IL-8: Quantikine, R&D sys-
tems), as described previously. The detection limits were
3.9 ng/liter for IL-1beta, 2.0 ng/liter for IL-6, 3.0 ng/liter for IL-8
and 10 ng/liter for TNF-alpha; the respective intraassay vari-
abilities for the lower assay range were 11%, 7%, 4% and 10%.
Incubation with leukocytes. Unfractionated leukocyte sus-
pensions were prepared from CPDA-anticoagulated blood
samples taken from healthy volunteers. Leukocytes were ob-
tained after sedimentation in the presence of 3% dextrane in
normal saline and hypotonic lysis of erythrocytes at 4°C. Cells
were washed twice in phosphate-buffered saline.
Fifty million leukocytes were incubated in 250 ml of serum-
free tissue culture medium (RPMI 1640, Sigma, Deisenhofen,
Germany) and 250 ml of patient plasma from CPDA-
anticoagulated blood specimen for 2 h at 37°C with 5% CO2.
As a positive and negative control, leukocytes were incubated
with RPMI medium and pooled plasma of 10 healthy donors
with or without lipopolysaccharide (1 mg/liter), respectively.
Abbreviations and Acronyms
CPDA 5 citrate, phosphate buffer, dextrose and adenine
GAPDH 5 glyceraldehyde-3-phosphate dehydrogenase
IL 5 interleukin
kb 5 kilobase
LAD 5 left anterior descending coronary artery
MI 5 myocardial infarction
PTCA 5 percutaneous transluminal coronary angioplasty
SDS 5 sodium dodecyl sulfate
SSC 5 saline sodium citrate
TNF-alpha 5 tumor necrosis factor-alpha
Table 1. Clinical Characteristics of Study Patients
Infarct Group
(n 5 10)
Control Group
(n 5 10)
Male/female 9/1 9/1
Mean age (yr) 59 57
Range 42–78 32–82
Location of culprit lesion
Prox LAD 3 1
Mid-LAD 6 9
Dist LAD 1 0
Coronary risk factor
Hypercholesterolemia 5 6
Systemic hypertension 6 4
Active smoking 6 5
Diabetes 2 2
Data presented are number of patients, unless otherwise indicated. Dist 5
distal; LAD 5 left anterior descending coronary artery; Prox 5 proximal.
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RNA preparation and Northern blot analysis. Total RNA
of 5 3 107 cells was isolated by the single-step method of
Chomczynski and Sacchi (24).
Five micrograms of the total RNA of each sample was
subjected to electrophoresis on a 1.2% agarose gel that
contained 0.1 mol/liter morpholinopropanesulfonis acid
(Boehringer, Mannheim, Germany), 40 mmol/liter sodium
acetate, 5 mmol/liter ethylenediaminetetraacetic acid (EDTA)
and 6% formaldehyde (Merck, Darmstadt, Germany). The
RNA was transferred to nylon membrane (Hybond-N, Amer-
sham, Braunschweig, Germany) in 20 3 saline sodium citrate
(SSC) buffer by capillary blotting overnight. Blots were baked
and prehybridized at 42°C in 50% formamide (Merck), 5 3
Denhardt’s (Sigma), 5 3 SSC, 0.5% sodium dodecyl sulfate
(SDS) and 20 mmol/liter salmon sperm DNA (Gibco BRL,
Eggenstadt, Germany). Blots were probed with the 1.05-
kilobase (kb) PST-I fragment of IL-1beta PBR322 (ATCC,
Rockville, Maryland), the 1-kb EcoRI fragment of IL-6
p91023(B) (ATCC), the 0.25-kb EcoRI–HindIII fragment of
IL-8 pUC18 (R&D systems, Minneapolis) and the 1.3-kb
HindIII–BamHI fragment of TNF-alpha pFC54.t (ATCC) and
reprobed with the 0.95-kb PST-I fragment of glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) pUC18 (gift from
Roger Becker, PhD, Toxikologisches Institut, University of
Mainz, Germany) to ensure the integrity of total RNA and
comparable RNA loading in each lane.
The cDNA probes were radiolabeled by random priming
with (alpha-P32) deoxycitosine triphosphate (dCTP) .6,000
Ci/mmol) (Amersham). The blots were washed at 60°C in 1%
SDS/2 3 SSC and autoradiographed with Kodak X-OMAT
film at 270°C with an intensifying screen.
Signal intensity was quantified by densitometry with back-
ground reduction using the Eagle-Eye system (Stratagene) and
Wincam-software (Windows, Berlin, Germany).
Intensity was expressed in relation to the GAPDH signal to
eliminate even minor differences in RNA loading.
Statistical analysis. The Kolkogorow-Smirnov test showed
that the data were not normally distributed. Therefore, results
are reported as median (interquartile range), and differences
were tested by the Wilcoxon matched-pairs signed-rank test,
unless otherwise indicated. A value of p , 0.05 was regarded
as significant.
Results
Baseline characteristics. There were no differences with
respect to gender distribution, age, localization of LAD steno-
sis and coronary risk factors between the study and control
groups (Table 1). In the study group, the delay between onset
of symptoms and the start of the intervention ranged from 3 to
9 h, and the median peak plasma creatine kinase concentration
was 2,751.5 6 1,891.1 U/liter.
Cytokine contents of plasma. The concentration of IL-6 in
the coronary sinus blood of patients with an acute MI in-
creased from 49.3 6 22.89 ng/liter before to 76.29 6 37.69
ng/liter after recanalization (p 5 0.021), and that of IL-8
increased from 56.56 6 23.09 to 64.38 6 25.79 ng/liter (p 5
0.012). Concentrations of IL-1beta and TNF-alpha were close
to the detection limits of the assays at all sampling conditions
and did not show significant changes (data not shown). There
was no appreciable cytokine release in the control group (data
not shown).
Induction of cytokine expression in leukocytes. In 9 of 10
patients with an acute MI, plasma obtained from the coronary
sinus after recanalization induced mRNA expression of IL-
1beta in normal donor leukocytes that was significantly higher
than that induced by coronary sinus plasma obtained before
recanalization (Fig. 1 [top] and 2) (p 5 0.017) and that induced
by simultaneously obtained aortic plasma (Table 2) (p 5
0.021). No significant differences in induction of IL-1beta
Figure 1. Top, Plot of IL-1beta mRNA expression in leukocytes after
incubation with coronary sinus plasma obtained before and 5 min after
recanalization in patients with acute MI. Bottom, Plot of IL-1beta
mRNA expression in leukocytes after incubation with coronary sinus
plasma obtained before and 5 min after elective PTCA in control
patients. Results are presented as percent of GAPDH, before versus
after recanalization or PTCA. Mean values (circles) 6 SD (vertical
bars) are also shown. *Significance versus zero.
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expression could be found between aortic and coronary sinus
plasma before recanalization (Fig. 2, Table 2). In none of the
sampling conditions did we find significant differences in
induction of IL-1beta mRNA-expression between aortic plasma
of patients with an acute MI and pooled healthy donor plasma
(Fig. 2).
We obtained similar results for the induction of IL-8
mRNA expression in normal leukocytes. The induction of IL-8
expression by coronary sinus plasma obtained after recanali-
zation was significantly higher in 8 of 10 patients with an acute
MI than that in coronary sinus plasma obtained before recan-
alization (Fig. 2 and 3 [top]) (p 5 0.032) and compared with
aortic plasma (Table 2) (p 5 0.005). No differences in induc-
tion of IL-8 expression could be observed between aortic and
pooled plasma from healthy donors (Fig. 2).
None of the changes found in patients with an acute MI
were found in the control group with elective PTCA (Fig. 1
[bottom] and 3 [bottom]). Neither coronary sinus plasma nor
aortic plasma from patients with an acute MI induced mRNA
expression of IL-6 or TNF-alpha that was different from that
induced by pooled healthy donor plasma (Fig. 2). mRNA
Figure 2. Northern blot analysis of representative experiments with
plasma obtained from patients with an acute MI undergoing recana-
lization (Study Group) and patients undergoing elective PTCA (Con-
trol Group). Shown is Northern blot analysis of total leukocyte RNA
extracted after a 2-h incubation with control plasma with 1 mg/liter of
lipopolysaccharide (LPS), control plasma (Co), aortic plasma (A1) and
coronary plasma (C1) before recanalization/PTCA; and aortic (A2)
and coronary plasma (C2) after recanalization/PTCA. The membranes
for Northern blot analysis were hybridized to IL-1beta, IL-6, IL-8,
TNF-alpha and GAPDH probes.
Table 2. Coronary Sinus–Aortic Differences in Leukocyte mRNA
Expression After Incubation With Plasma From Patients With an
Acute Myocardial Infarction (percent of glyceraldehyde-3-phosphate
dehydrogenase)
Before Recanalization After Recanalization
Median
(quartiles) p Value*
Median
(quartiles) p Value*
IL-1beta 3 (23, 5) 0.140 45.5 (23, 115) 0.021
IL-6 0.5 (21, 3) 0.858 0 (0, 0.5) 0.753
IL-8 0 (22, 5) 0.441 16 (4, 52) 0.005
TNF-alpha 20.5 (26, 1) 0.484 0 (25, 4) 0.800
*Level of significance for coronary sinus–aortic values different from zero.
IL 5 interleukin; TNF 5 tumor necrosis factor.
Figure 3. Top, Plot of IL-8 mRNA expression in leukocytes after 2-h
incubation with coronary sinus plasma obtained before and 5 min after
recanalization in patients with acute MI. Bottom, Plot of IL-8 mRNA
expression in leukocytes after incubation with coronary sinus plasma
obtained before and 5 min after elective PTCA in control patients.
Results are presented as percent of GAPDH, before versus after
recanalization or PTCA. Mean values (circles) 6 SD (vertical bars)
are also shown. *Significance versus zero.
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expression of IL-1beta or IL-8 induced by coronary sinus
plasma could not be related to the cytokine contents analyzed.
Discussion
In the present study we investigated the effect of plasma
from the ischemic and reperfused heart on cytokine expression
in leukocytes. We found an induction of IL-1beta and IL-8
mRNA expression in leukocytes by coronary sinus plasma
obtained after recanalization of the occluded artery. The
results of the study indicate that the ischemic and reperfused
coronary circulation in acute MI represents a proinflammatory
environment that induces cytokine expression in leukocytes.
Role of cytokines in reperfusion. In our previous study (6)
we revealed neutrophil activation and release of the proinflam-
matory cytokines IL-8 and IL-6 as evidence of cardiac inflam-
matory responses in reperfused acute MI. In addition to these
results, our present study indicates that leukocytes may serve
as a source for IL-8 and IL-1beta in the regulation of infarct-
related cardiac inflammatory responses. Moreover, even
though we do not present direct evidence, our data suggest that
IL-1beta may participate in the paracrine regulation of inflam-
mation during ischemia and reperfusion. It was previously
shown in animal models that cardiac lymph, collected during
ischemia and reperfusion, activates neutrophils (25,26) and
induces IL-8 mRNA expression in cultured canine endothelial
cells (27). To our knowledge the present study is the first to
show the induction of cytokine expression in leukocytes by
plasma obtained from patients with an acute MI during
reperfusion. Thus, the results extend our knowledge about the
role of leukocytes in the inflammatory responses in acute MI.
The capability of coronary sinus plasma to induce IL-1beta
and IL-8 became apparent only after recanalization of the
occluded vessel. No induction of cytokine expression in leuko-
cytes could be observed in the control patients with elective
PTCA. Thus, the observed effects cannot be attributed to the
procedure itself but appear to be closely related to ischemia
and reperfusion of the heart.
The induction of IL-1beta and IL-8 in leukocytes by coro-
nary sinus plasma obtained after recanalization of the infarct-
related artery could not be explained by the plasma contents of
IL-1beta, IL-6, IL-8 or TNF-alpha. Thus, our study provides
evidence that besides the previously investigated cytokines,
additional mediators or the metabolic conditions of ischemia
and reperfusion, or both, contribute to inflammatory activation
of leukocytes. This may affect resident, inflowing and passing
leukocytes in the reperfused heart. Hence, the present study
suggests a potential role of leukocytes in the regulation of both
local and systemic inflammatory responses in patients with an
acute MI.
IL-1beta stimulates inflammatory cells like leukocytes, fibro-
blasts and endothelial cells; modulates adhesion molecules;
and induces systemic inflammatory reactions like the expres-
sion of acute-phase proteins in the liver (18). IL-8 is involved
in various chemotactic, proinflammatory and reparative func-
tions and is specific for neutrophil activation (21,22,27). IL-8 is
produced by many cell types, even though the predominant
source appears to be the endothelium (20). Endothelial cells
release IL-8 under hypoxic conditions (28). Our data suggest
that resident and inflowing leukocytes may extend the early
release of IL-8 by the vascular endothelium during reperfu-
sion.
IL-6 is a major cytokine in unstable angina and acute
myocardial infarction, both locally and systemically (6,29).
Nevertheless, in the present study we could not detect a
plasma-induced early IL-6 expression in leukocytes. Thus, we
conclude that mediators contained in the plasma may not
contribute to the elaboration of this cytokine by leukocytes.
The IL-6 release in unstable angina (29) and acute MI (6) is
sufficiently explained by the known hypoxia-induced liberation
by endothelial cells and cardiac myocytes (23,30). TNF-alpha
has been shown (15) to be involved in neutrophil–myocyte
adhesion after ischemia–reperfusion injury in the canine
model. Available clinical data (6), including those of the
present study, have not been able to suggest an important role
for TNF-alpha in the modulation of inflammatory responses
after reperfusion.
Limitations of the study. In the present study we investi-
gated the production of cytokines that are known to be
regulated transcriptionally (31,32). Therefore, analysis of
mRNA expression in leukocytes by Northern blot is an appro-
priate experimental approach to the study objective. Even
though posttranscriptional or posttranslational modulation of
cytokine expression in leukocytes has not been shown to play
an essential role (33), our argument could have been strength-
ened by assaying the protein levels in the supernatants. How-
ever, the critical condition of our patients with an acute MI did
not allow us to collect sufficient amounts of blood from the
coronary sinus for further incubation experiments.
The limited quantity of coronary sinus blood also prevented
us from analyzing subpopulations of leukocytes. We thus
present data based on cytokine expression in unfractionated
leukocytes. However, it is known that monocytes are one of the
most important sources for cytokines (34,35), even though
both granulocytes and monocytes are involved in cytokine
production (36).
Our results demonstrate the induction of cytokine expres-
sion by coronary sinus plasma, but we did not investigate the
mechanism by which leukocytes are activated. We did not find
a correlation of IL-6 and IL-8 content in coronary sinus plasma
and the induction of mRNA expression, but these two cyto-
kines represent only a small part of potential mediators. Other
reports (9,25,37) have described the induction of cytokine
expression in leukocytes, for example, by complement fractions
or platelet-activating factor. Additional mediators, such as
leukotrienes or chemokines like MCP-1 or RANTES, may also
contribute to the leukocyte-modulated inflammatory reactions
(7, 8, 19, 38). Likewise, we cannot exclude an effect of traces of
IL-1beta and TNF-alpha below the detection limits of our
assays. Further experiments with blocking antibodies or heat
inactivation of plasma components may help in the identifica-
tion of the factors responsible for the observed effects.
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Clinical perspectives. Early recanalization of the occluded
artery in patients with an acute MI reduces mortality and may
preserve left ventricular function (1–5). However, local and
systemic inflammatory reactions of the ischemic and reper-
fused heart may compromise the clinical outcome (10–14).
Administration of adjunctive therapies at the time of reperfu-
sion may reduce deleterious inflammatory effects and improve
the outcome of reperfusion. Our findings, that leukocyte
IL-1beta and IL-8 expression is induced in the ischemic and
reperfused heart, may assist in the design of therapeutic
strategies aimed at reducing inflammatory responses.
Leukocyte-derived cytokines may thus be a promising pharma-
cologic target for modulating inflammatory responses during
reperfusion.
We thank Kathrin Schulz and Tanja Breustedt for excellent technical assistance.
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